Sunday, June 10, 2012


Plant-based skin grafts hold promise for burns and wounds

Eqalix has licensed plant-based synthetic skin graft technology and other techniques from Drexel University, the University of Pennsylvania and The Children's Hospital of Philadelphia. The license includes vascular graft and tissue regeneration technologies, and the three institutions will be stakeholders in the venture. Drexel's Coulter Translational Research Partnership funded the development of alimentary protein scaffolds and grafts. (6/7